People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sydecar, Inc. | — | Other Technology | Series A | $27.3M | $52.9M | 2021 |
| Meditope Biosciences, Inc. | — | Biotechnology | Seed | $3.7M | $72.1M | 2013 |
Stephanie Hsieh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephanie Hsieh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Goldberg | 1 | 11 |
| Daniel Kimerling | 1 | 3 |
| David Meister | 1 | 2 |
| Nikhil Talreja | 1 | 2 |
| Robert McKenzie | 1 | 2 |
| Heng Wei Chang | 1 | 2 |
| George Prendergast | 1 | 1 |
| Rob Kramer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.